Atlas Trials

Hydroxyurea and Magnesium Pidolate to Treat People With Hemoglobin Sickle Cell Disease

Clinical trial NCT00532883 · TERMINATED

Trial details

NCT number
NCT00532883
Sponsor
St. Jude Children's Research Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hemoglobin SC Disease
Start date
2007-01-01
Primary completion
2009-03-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.